Trial Profile

PERICLES (PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study)-a Phase 2 Study of Atezolizumab With or Without Radiotherapy in Penile Cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

10 Apr 2024 Results assessing overall survival and potential biomarkers for immunotherapy response presented at the 115th Annual Meeting of the American Association for Cancer Research
24 Jul 2023 Results assessing safety and efficacy of Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis published in the Journal of Clinical Oncology
09 May 2023 Planned End Date changed from 1 Dec 2023 to 15 Sep 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com